Share

    


In This Section

Home / Learn / Breast Cancer

Breast Cancer

Among American women, breast cancer is the most common cancer, after skin cancer. About 1 in 8 (12 percent) women in the U.S. will develop invasive breast cancer during their lifetime.

For 2018, the American Cancer Society estimates that:

  • About 266,120 new cases of invasive breast cancer will be diagnosed in women, and about 2,470 will be diagnosed in men.
  • About  63,960 new cases of carcinoma in situ (CIS) will be diagnosed (CIS is non-invasive and is the earliest form of breast cancer).
  • About 40,920 women will die from breast cancer.

Incidence rates of breast cancer are highest in non-Hispanic white women; however, breast cancer death rates are highest in African American women. 
Source: American Cancer Society Breast Cancer Facts & Figures 2017-2018.

Breast cancer is the second leading cause of cancer death in women, surpassed only by lung cancer. Death rates from breast cancer have been declining since about 1989, with larger decreases in women younger than age 50. It is believed that earlier detection through screening and increased awareness, as well as improved treatment, has led to these decreases.

Today, there are more than 3.1 million breast cancer survivors in the U.S., including those still being treated and those who have completed treatment.
Source: American Cancer Society. Cancer Facts and Figures 2018. Atlanta, Ga: American Cancer Society; 2018.

Featured Programs

Advanced Genetic Testing for Metastatic Breast Cancer Patients

The Association of Community Cancer Centers (ACCC) has joined with the Oncology Nursing Society (ONS) and The France Foundation to support a series of live Grand Rounds/Tumor Boards, “PARP Inhibitors: Advancing Personalized Medicine for Metastatic Breast Cancer Patients.”

ACCC member cancer programs are invited to participate in a live Grand Rounds program where a subject matter expert will travel to participating institutions to lead a one-hour accredited session. The Grand Rounds will provide the multidisciplinary cancer team with strategies to appropriately incorporate genetic testing and poly (ADP-ribose) polymerase (PARP) inhibitor therapy for patients with metastatic breast cancer (MBC).

Learn More & Apply 
 

Metastatic Breast Cancer Project's Latest Publication Features Cancer Programs Advancing Care Delivery and Support 

The ongoing ACCC Metastatic Breast Cancer project is working to expand multidisciplinary team awareness of how to effectively meet the holistic needs of metastatic breast cancer patients, enhance patient-provider communication, and improve the patient-centeredness of care delivery. The project's latest publication, Metastatic Breast Cancer: Effective Principles in Actionbuilds on the six principles for reframing provider-patient conversations identified in the Metastatic Breast Cancer Workbook. Read how three cancer programs are integrating these principles as they advance their care for this patient population. Learn more.

"Dandelion Toolkit" QI Study
U.S.-based cancer programs and practices have the opportunity to join in a quality improvement (QI) study by testing the new “Dandelion Toolkit” designed to support clear communication, empowering both metastatic breast cancer patients and their healthcare providers. Toolkits provided to participants free of charge.

Learn More & Apply

Quality Improvement in Breast Cancer Through BRCA Testing

To support quality improvement projects in breast cancer, the Association of Community Cancer Centers (ACCC) has joined with Pfizer Independent Grants for Learning and Change (IGLC) to issue a Request for Proposals (RFP) with the intent of funding QI initiatives that fully integrate BRCA testing into patient care plans in order to help inform the treatment decision-making process.
Learn More

Managing Patients with HER2+ Breast Cancer 

ACCC is partnering with AXIS Medical Education in an educational research project to assess the value of a robust, independent, quality-focused educational intervention that aims to improve a community cancer program's quality measures related to management of patients with HER2+ breast cancer (all stages). Two ACCC-member Cancer Programs are participating in the project. 
Learn More

 

ACCCBuzz Blog Posts

From Oncology Issues

  •  Highlights from ASCO 2018
    By Cary A. Presant, MD, FACP, FASCO
    ASCO 2018 offered a wealth of new data that will continue to transform clinical practice and cancer program development. Most important, implementation of the scientifi c advances we learned at ASCO 2018 will improve the length and quality of life of our cancer patients.
  •  Breast Care ACCESS Project
    By Sharon Lieb Inzetta, RN, MS, CBCN, CN-BN, ONN-CG, and Laura L. Mussara, BS, MBA
    Through its Breast Care ACCESS Project, Summa Health redesigned its breast cancer care continuum to address disparities in treatment, reducing patient outmigration, increasing procedures and referrals, and lowering wait times.
  •  Creating a Place for Late-Stage Breast Cancer Patients
    Timothy J. Pluard, MD; Jane Peck; and Emily Kayrish
    Saint Luke’s Hospital’s Koontz Center for Advanced Breast Cancer is one of the only centers in the United States dedicated solely to the comprehensive care of women with late-stage breast cancer.
  •  Closing the Loop with a Post-Biopsy Breast Clinic
    Kimberly C. Hutcherson, MD, and Katherine S. Michaud, MPA
    The Gwinnett Medical Center Breast Program Leadership Team saw an opportunity to create a more comprehensive diagnostic care pathway to include more timely results to breast biopsy patients, streamlined access to treatment specialists, and improved processes and communication with referring physicians.
  •  A Time for Healing: An Annual Retreat for Breast Cancer Survivors
    Debbie DeNitto
    To help meet the unique needs of its breast cancer patients post-treatment, the cancer program at Winchester Medical Center hosts an annual overnight fall retreat (Saturday-Sunday).
  •  Onco-Contraception for Women Diagnosed with Breast Cancer
    Erika K. Radeke, MPS; Alicia Roston, MPH; Shweta Bhatt, MD; Arden Roston, BA; Lindsay Zimmerman, MPH; Louis G. Keith, MD, PhD; and Ashlesha Patel, MD, MPH
    While contraceptive counseling during breast cancer diagnosis and treatment should be an integral part of disease management, it is often overlooked by clinicians.
  •  Best of ASCO 2017
    Cary A. Presant, MD, FACP, FASCO
    ASCO 2017 was filled with new information and long lines as 39,000 oncologists worldwide came together to hear the latest advances in cancer care.
  •  Views: Are You Dense? My Journey to Patient Breast Health Advocacy
    Nancy M. Cappello, PhD
    Nearly 13 years ago, I slipped through a significant and potentially fatal crack in our healthcare system when I was diagnosed with advanced stage breast cancer.
  •  Peer Mentoring: A Volunteer-Run Program Benefits Breast Cancer Patients & Survivors
    Dona Hobart, MD, and Marcia McMullin, RN, BSN, MA
    With the understanding that one-to-one mentoring services have proven effective in improving both quality of life and survival rates, the Center for Breast Health at Carroll Hospital developed a volunteer-run peer mentor program, Embrace Peer, in April 2014.
  •  A Pathway for Identifying Women at Increased Risk for Breast Cancer and Providing Personalized Management and Risk Reduction
    S. Kate Hughes, MS, CGC
    In the summer of 2014 staff at the Novant Health Derrick L. Davis Cancer Center (NHDLD Cancer Center), Winston-Salem, N.C., developed a screening method aimed at detecting women in our community who are at increased risk for breast cancer.
  •  Compliance with Breast Cancer Post-Therapy Surveillance
    Melissa Carandang, MD; Wesley Babaran, MD; Lawrence Wagman, MD; Lianne Nacpil, MPH, CTR; Timotea Lara, RN, MSN, NP-C; Norma Castro; and Shannin Greene
    In 2011, Center for Cancer Prevention and Treatment at St. Joseph Hospital initiated a study to measure patient compliance with post-therapy surveillance in women treated using state and federal safety net funding.
  •  Beyond Breast Conservation: Oncology Surgery in the Community Setting
    Paul Baron, MD, FACS, and Josh Mondschein, MD, MSCI
    Cancer programs that do not currently have specialists who offer oncoplastic surgery to their breast cancer patients should consider learning more about these procedures and setting up a program to offer these services.

In the News